# Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis

> **NCT01440309** · PHASE1 · UNKNOWN · sponsor: **Robert Chunhua Zhao, MD, PhD** · enrollment: 20 (estimated)

## Conditions studied

- Primary Biliary Cirrhosis

## Interventions

- **BIOLOGICAL:** Biological: mesenchymal stem cell
- **DRUG:** ursodeoxycholic acid

## Key facts

- **NCT ID:** NCT01440309
- **Lead sponsor:** Robert Chunhua Zhao, MD, PhD
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01440309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01440309, "Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01440309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*